that circadian changes in drug metabolism might also influence the peak time of its activity. A recent study of human transcriptional rhythms also identified PPARa to be circadian in its expression in human liver (Anafi et al., 2017) . Whether this is impacted by obesity or diet remains to be elucidated. In order to fulfill the promise of chronotherapy, a more detailed knowledge is needed of the impact of circadian rhythms on the expression and activity of a drug target, the pharmacokinetics and metabolism of the drug and the potential for the expression of unwanted targets in both the target tissue and the tissues responsible for toxicity. Obtaining these data around the clock in model organisms such as mice is feasible. However, obtaining significant numbers of samples for analysis from people will be a challenge. It is likely that the general concepts learned from the model organisms will also be true in humans, though important species-specific differences including known differences in drug metabolism are likely to be present.
Several other interesting questions are raised by this study. The authors utilize a model of diet-induced obesity in which the diet was high in fat and sucrose. It remains to be determined whether specific dietary constituents, obesity, or both independently influence the circadian changes described. While the study clearly shows that diet-induced obesity induces profound changes in circadian gene expression, the components of the core clock that are required for this change remains to be determined. Another hypothesis worth exploring would be that metabolites altered by the change in diet or body composition influence the activity of enzymes involved in chromatin modification and that these influence the activity of circadian enhancers (Sassone-Corsi, 2016) . Circadian metabolomic studies combined with studies of chromatin modification in models of diet-induced obesity around the clock could address this idea (Krishnaiah et al., 2017) . These mechanistic details notwithstanding, this study substantially enhances our understanding of how diet-induced obesity alters the circadian epigenome and transcriptome to exert major effects on metabolism. Bass, J., and Lazar, M.A. (2016 Viruses have evolved inhibitors to counteract the CRISPR immune response, but they are not fully potent and need some time to be expressed after the beginning of infection. In this issue of Cell, Borges et al. and Landsberger et al. show that sequential infection gradually immunosuppresses the host to allow effective CRISPR inhibition.
Bacteria and the viruses that infect them, known as bacteriophages, have co-evolved over billions of years, giving rise to myriad innovative defensive and offensive strategies to combat one another. The most recent anti-phage defense systems to be thoroughly characterized are CRISPR-Cas systems that protect the bacterial host via cleavage of viral nucleic acid. All CRISPR loci contain a set of associated (cas) genes and an array containing sequences derived from foreign nucleic acids (spacers). Transcription and processing of spacer sequences in the array produces short CRISPR RNAs (crRNAs) that direct the destruction of foreign DNA by Cas nucleases (Marraffini, 2015) . To combat CRISPR-Cas immunity, phages have developed anti-CRISPR (Acr) proteins that function by blocking CRISPR-Cas DNA binding or cleavage (Bondy-Denomy et al., 2013 , 2015 Pawluk et al., 2016) . These inhibitors have been shown to generate potent neutralization of CRISPR in vitro and when they are overexpressed in heterologous systems, but how they operate in their native context has remained unresolved. This question remained particularly vexing given the observation that digestion of the phage genome by CRISPR-Cas surveillance complexes in vivo can occur as quickly as 2 min post-infection (Garneau et al., 2010) , suggesting that the production of the inhibitor by the infecting phage may not occur rapidly enough to escape immunity. In this issue of Cell, Borges et al. (2018) and Landsberger et al. (2018) report that successful inhibition of CRISPR in Pseudomonas aeruginosa is not complete during the first round of infection but that acr expression compromises the host CRISPR-Cas response to the second round of infection. Thus, inhibition by Acr proteins requires phages to cooperate to immunosuppress their hosts (Figure 1) .
Pseudomonas aeruginosa is naturally infected by phages encoding different acr genes targeting its type I-F CRISPRCas system. However, acr-phages do not completely inhibit CRISPR immunity (Bondy-Denomy et al., 2013) . Both groups showed that, rather than a binary response, there are a range of infection outcomes that depend on the strength of CRISPR targeting (the more spacers that target the phage, the stronger) on one hand and the strength of the Acr inhibition by the phage on the other. To eliminate some of these variables, both groups engineered the non-acr DMS3 bacteriophage to express acr genes from different phages using the same promoter and targeted it with the same spacers. They found that the success of Acr inhibition depends on the multiplicity of infection: the more phages that infect a single host, the worse the CRISPR-Cas defense. This result led to the hypothesis that multiple acr-phages need to deliver multiple doses of inhibitor to achieve immunosuppression of the host.
Each group investigated this hypothesis using different approaches. Acr proteins targeting P. aeruginosa CRISPR systems have been found exclusively in lysogenic bacteriophages, which can integrate into the host genome. Borges et al. (2018) infected CRISPR cells with a mixture of unmarked acr-phages and gentamycin-marked phages lacking inhibitors. It was found that infection with acr-phages significantly increased the rate of lysogenization of the antibioticmarked phages. Furthermore, when the authors assayed for the presence of the integrated virus in the bacterial genome, they exclusively found the marked phages present, demonstrating that only these viruses had successful infections. Together, these results showed that unproductive infections by acr-phages allow for successful lysogeny by immunosuppressing the host. In this regard, Acr proteins can benefit the larger viral community, and therefore, their mechanism of action is reminiscent of earlier work in bacteriophage lambda (Zeng et al., 2010) , in which lambda infection increases the intracellular concentration of the repressor protein (which inhibits the lytic cycle of the virus), thereby increasing the probability of lysogenization in subsequent infections. This suggests that viral During the first infection cycle, inhibitors are produced by infecting phages but cannot act on the CRISPR-Cas machinery quickly enough to abrogate phage degradation. However, the inhibitors leave the host immunosuppressed for the next round of infection, in which phages encounter an inactivated CRISPR-Cas response and are able to overcome it. strategies aimed at modulating the intracellular environment of the host in anticipation of secondary infections may be more widely utilized that previously thought.
Using a complementary approach, Landsberger et al. (2018) developed a theoretical model that required cooperation between phages that sequentially immunosuppress the host in order to explain their experimental data. They then set out to test this hypothesis using plasmid transformation of cells previously infected by acr-phages. The authors first immunosuppressed cells by infecting them with different acr-phages and then tested the status of the CRISPR-Cas immune response by introducing plasmids containing the same phage target sequences via transformation. Whereas cells pre-infected with wild-type phages readily degrade transformed plasmids via CRISPR, cells exposed to acr-phages are unable to target these DNAs. In addition to demonstrating the immunosuppressive cooperation of acr-phages, these experiments also raise the possibility that Acr donation by bacteriophages represents a public good that benefits not only clonal populations of phage but other mobile genetic elements as well.
The most common way for phages to avoid type I-F CRISPR immunity is the selection of target escape mutations that abrogate recognition and cleavage by Cas nucleases (van Houte et al., 2016) . Critically, both groups show that in the presence of acrs, virtually all the phages produced at the end of infection are genetically identical to their parental virion. For phages with compact genomes where nearly every gene is essential, Acr expression may therefore be a way for phages to maintain genomic stability and avoid CRISPR immunity simultaneously. Still, the observation that acr-phages propagate most effectively at high densities raises the possibility that target escape mutations that allow for viral replication may be somewhat required for generating immunosuppression. Future studies will be needed to characterize the interplay, if any, between these two strategies of overcoming CRISPR.
In addition to solving the mystery of the anti-CRISPR mechanism of action, these studies also contribute to the appreciation of bacteriophages not just as independent actors but as participants in groups capable of collective actions. For example, a recent study in Bacillus subtilis demonstrated that phages encode an intercellular communication system that coordinates entry into the lysogenic cycle (Erez et al., 2017) . Borges et al. (2018) and Landsberger et al. (2018) add to this growing concept of phage cooperation by showing that an initial altruistic, but failed, infection by an individual virus benefits the whole population by weakening the host. Phages are thought to exist in complex heterogeneous communities of several species, and therefore, future studies will be needed to address whether CRISPR inhibitors preferentially benefit related phages or all members of the community. Bacteria employ multiple defense systems, and much is left to be discovered as we continue to unravel the increasingly complex ecology of phage-bacteria interactions.
